/PRNewswire/ Canntab Therapeutics Limited ("Canntab" or the "Company") (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1), the leading innovator in cannabinoid and terpene.
Canntab Therapeutics Ltd (CSE:PILL, OTCQB:CTABF) said it has closed a non-brokered private placement of secured convertible debentures of the company, under.
An antitrust lawsuit filed this week by St. Francis Hospital and Medical Center that accuses its crosstown rival Hartford HealthCare of creating a monopoly on certain services, has once again put the spotlight on industry consolidation, particularly the trend of physician group acquisitions.